Michael R. Michaelides
AbbVie (United States)(US)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Synthesis and biological activity, Click Chemistry and Applications
Most-Cited Works
- → Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours(2017)825 cited
- → Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a(2014)185 cited
- → Discovery ofN-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor(2007)184 cited
- → Trifluoromethyl ketones as inhibitors of histone deacetylase(2002)147 cited
- → The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity(2017)128 cited
- → Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC)(2002)113 cited
- → The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia(2015)94 cited
- → α-Keto amides as inhibitors of histone deacetylase(2003)81 cited
- → Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases(2017)72 cited
- → NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability(2002)56 cited